Adding a GLP-1 receptor agonist as a coadjutant therapy in the early post-transplant period to the appropriate patient brings good metabolic outcomes and also is safe, Mario Campana, MD, fellow in the division of endocrinology, diabetes and metabolism at the Heersink School of Medicine at the University of Alabama at Birmingham (UAB), told Healio
And therefore, it has a huge role to play in things like diabetes, hypertension, dyslipidemia, Alzheimer's, and heart disease
It's perfectly fine for a single-use application where you intend to use the entire reconstituted volume immediately
Maodobra-Mazur, M., Cierzniak, A., Myszczyszyn, A., Kaliszewski, K
The Asia Pacific GLP-1 industry is projected to record the highest growth rate during the forecast period